Heterocyclic derivatives as inhibitors of factor Xa
US6723723B1 · kind B1 · utility
Assignee
Inventor
Key dates
| Filing date | Nov 15, 2001 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Nov 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to heterocyclic derivatives, or pharmaceutically-acceptable salts thereof, of formula (I) wherein: A is an optionally substituted 5- or 6-membered monocyclic aromatic ring containing 1, 2 or 3 ring heteroatoms selected from oxygen, nitrogen and sulphur atoms; which possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to phaautical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.